These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35847975)

  • 1. Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery.
    McKay K; Hamilton NB; Remington JM; Schneebeli ST; Li J
    Front Mol Biosci; 2022; 9():879212. PubMed ID: 35847975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the Modeling of Extracellular Ligand Binding Pockets in RosettaGPCR for Conformational Selection.
    Liessmann F; Künze G; Meiler J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.
    Vilar S; Ferino G; Phatak SS; Berk B; Cavasotto CN; Costanzi S
    J Mol Graph Model; 2011 Feb; 29(5):614-23. PubMed ID: 21146435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective ensemble docking of allosteric modulators in an adenosine G-protein-coupled receptor.
    Bhattarai A; Wang J; Miao Y
    Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129615. PubMed ID: 32298791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Anopheles gambiae octopamine receptor and discovery of potential agonists and antagonists using a combined computational-experimental approach.
    Kastner KW; Shoue DA; Estiu GL; Wolford J; Fuerst MF; Markley LD; Izaguirre JA; McDowell MA
    Malar J; 2014 Nov; 13():434. PubMed ID: 25407998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Conformational State Transitions of Class B GPCRs Using Molecular Dynamics.
    Liao C; May V; Li J
    Methods Mol Biol; 2019; 1947():3-19. PubMed ID: 30969408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensemble-based docking using biased molecular dynamics.
    Campbell AJ; Lamb ML; Joseph-McCarthy D
    J Chem Inf Model; 2014 Jul; 54(7):2127-38. PubMed ID: 24881672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing an ensemble docking-based virtual screening strategy for kinase targets by considering protein flexibility.
    Tian S; Sun H; Pan P; Li D; Zhen X; Li Y; Hou T
    J Chem Inf Model; 2014 Oct; 54(10):2664-79. PubMed ID: 25233367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?
    Ballante F; Kooistra AJ; Kampen S; de Graaf C; Carlsson J
    Pharmacol Rev; 2021 Oct; 73(4):527-565. PubMed ID: 34907092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes.
    Wada M; Kanamori E; Nakamura H; Fukunishi Y
    J Chem Inf Model; 2011 Sep; 51(9):2398-407. PubMed ID: 21848279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Binding Pocket Optimization for Virtual High-Throughput Screening (vHTS) Drug Discovery.
    Gazgalis D; Zaka M; Abbasi BH; Logothetis DE; Mezei M; Cui M
    ACS Omega; 2020 Jun; 5(24):14297-14307. PubMed ID: 32596567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexible receptor docking for drug discovery.
    Wong CF
    Expert Opin Drug Discov; 2015; 10(11):1189-200. PubMed ID: 26313123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists.
    Engel S; Skoumbourdis AP; Childress J; Neumann S; Deschamps JR; Thomas CJ; Colson AO; Costanzi S; Gershengorn MC
    J Am Chem Soc; 2008 Apr; 130(15):5115-23. PubMed ID: 18357984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
    Tarcsay A; Paragi G; Vass M; Jójárt B; Bogár F; Keserű GM
    J Chem Inf Model; 2013 Nov; 53(11):2990-9. PubMed ID: 24116387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics.
    Kumar R; Jade D; Gupta D
    J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes: Impact of ligand type and receptor activation state.
    Thomas BN; Parrill AL; Baker DL
    J Mol Graph Model; 2022 May; 112():108119. PubMed ID: 34979368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.